Details for Patent: 5,543,152
✉ Email this page to a colleague
Summary for Patent: 5,543,152
Title: | Sphingosomes for enhanced drug delivery |
Abstract: | Liposomal formulations having extended circulation time in vivo and increased drug retention are comprised of sphingomyelin and cholesterol and have an acidic intraliposomal pH. The formulations have enhanced stability and thus are used in methods which provide improved drug delivery and more effective treatment. The delivery of lipophilic drugs such as the vinca alkaloids, and particularly vincristine and vinblastine, to tumors is significantly improved. |
Inventor(s): | Webb; Murray S. (Vancouver, CA), Bally; Marcel B. (Bowen Island, CA), Mayer; Lawrence D. (North Vancouver, CA) |
Assignee: | Inex Pharmaceuticals Corporation (Vancouver, CA) |
Application Number: | 08/263,603 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Delivery; Compound; Process; Formulation; |
Drugs Protected by US Patent 5,543,152
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,543,152
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 248586 | ⤷ Sign Up | |||
Australia | 2709495 | ⤷ Sign Up | |||
Canada | 2193502 | ⤷ Sign Up | |||
Germany | 69531701 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |